News & Updates
Filter by Specialty:
EGFR-related skin AE rates drop with COCOON regimen
Interim data from the phase II COCOON trial demonstrate the potential of the COCOON dermatologic management (DM) regimen to significantly reduce the incidence and severity of dermatologic adverse events (dAEs) tied to amivantamab plus lazertinib treatment in patients with EGFR-mutant (EGFRm) non-small cell lung cancer (NSCLC).
EGFR-related skin AE rates drop with COCOON regimen
14 May 2025
Fluid restriction good for chronic HF: Aye or nay?
Allowing patients with chronic heart failure (HF) to drink as much fluid as they need appears to present no additional risks, including for hospitalization and death, as shown in the FRESH-UP study presented at ACC.25. This finding challenges the current US and EU recommendations to limit daily fluid intake to 1.5 L for this population.
Fluid restriction good for chronic HF: Aye or nay?
14 May 2025
Life quality poorer in COVID-19 survivors with ongoing symptoms
In adults who have survived the COVID-19 pandemic, health-related quality of life (HRQoL) is high among those who had either recovered from post-COVID-19 condition (PCC) or had never been afflicted with PCC, according to a study.
